11
Views
1
CrossRef citations to date
0
Altmetric
Session IV: Congestive Heart Failure and ACE Inhibition

Ace Inhibitors in Heart Failure

Pages 115-120 | Published online: 27 Oct 2016

References

  • Braunwald E.; Heart failure: Pathophysiology and treatment. Am. Heart J. 102: 486–490, 1981.
  • Chatterjee K., Rouleau J.-L.: Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure in acute and longterm management of myocardial ischemia. Acta Mat. Sauid suppl 651, 295–302, 1981.
  • Colucci W.S., Wynne J., Holman B.L. and Braunwald E.: Long-term therapy of heart failure with prazosin: A randomized double blind trial. Am. J. Cardiol, 45:337–344, 1980.
  • Dzau V.J., Colucci W.S., Hollenberg N.K., Williams G.H.: Relation of renin angiotensin aldosterone system to clinical state in congestive heart failure. Circulation 63: 545–651, 1981
  • Elkayam U., Lejemtel T.H., Mathur M., Ribner H.S., Frishman W.H., Strom J., and Sonnenblick E.H.: Marked early attenuation of hemodynamic effects of oral prazosin therapy in congestive heart failure. Am. J. Cardiol, 44: 540–545, 1979.
  • Ertl G., Kloner R.A., Alexander R.W., Braunwald E.: Limitation ot experimental infarct size by angiotensin–converting enzyme inhibitor. Circulation 65: 40–48 1982.
  • Fernandez L.A., Caride V.J., Twickler J., Galardy R.E.: Renin-angiotensin and development of collateral circulation after renal ischemia. Am. J. Physiol 243: H869–H875, 1982.
  • Ferris T.F., Weir E.K.: Effect of captopril on uterine blood How and prostaglandin E. synthesis in the pregnant rabbit. J. Clin. Invest 71: 809–815, 1983.
  • Fitzpatric D., Nicholls M.G., Ikram H., Espiner E.A.: Haemodynamic, hormonal and electrolyte eltects of enalapril in heart failure. Br. Heart J. 50: 163–169, 1983.
  • Fouad F.M., El-Tobgi S., Tarazi R.C., Bravo E.L., Hart N.J., Shirey E.K., Lini J.: Captopril in congestive heart failure resistant to other vasodilators. Eur. Heart J. 5: 47–54, 1984.
  • Franciosa J.A., Pierpont G., and Cohn J.N.: Hemodynamic improvement after oral hydralazine in left ventricular failure. An Int. Med., 86: 388–393, 1977.
  • Franciosa J. A.: Long term vasodilator therapy of chronic left ventricular failure: does it work? Int. J. Cardiol 5: 433–439, 1984.
  • Hughes J., Roth R.H.: Evidence that angiotensin enhances transmittor release during sympathetic nerve stimulation. Br. J. Pharmacol 41: 239–255, 1971.
  • Kjekshus J.K., Søyland E., Dickstein K., Abrahamsen A.M., Gundersen T.: Sustained haemodynamic effects of enalapril in left ventricular failure. J. Hypert 1: 143–145, 1983.
  • Kumar S., Shahabuddin S., Haboubi N., West D., Arnold F., Reid H., Carr T.: Angiogenesis tactor from human myocardial infarcts. Lancet II: 364–368, 1983.
  • Levine T.B., Olivari M.T., Garberg V., Sharkey S.W., Cohn J.N.: Hemodynamic and clinical response to enalapril, a long-acting converting- enzyme inhibitor, in patients with congestive heart failure. Circulation 69: 548–553, 1984.
  • Massie B., Kramer B., Topic N., Henderson S.G.: Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. Circulation 65: 1374–1381, 1982.
  • Navis G.J., de Jong P.E., Kallenberg C.C.M., de Monchy J., Zeeuw D.: Absence of cross-reactivity between captopril and enalapril. Lancet I: 1017, 1984.
  • Packer M., Meller L, Gorlin R., and Herman M.V.: Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation 58: 531–539, 1979.
  • Pipkin F.B., Symonds E.M., Turner S.R.: The effect of captopril upon mother and fetus in the chronically cannulaied ewe and in the pregnant rabbit. J. Physiol. 323: 415–422 1982.
  • Pouleur H., Engler R.L., Printz MP., Covell J.W.: Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload. Eur. J. Clin. Invest 13:331–338, 1983.
  • Parmeley W. W., Chatterjee K., Arnold S., Rubin S.A., Brundage B.H., Williams R.L., Ports T., Chuck L. and Roleau J.: Hemodynamic effects ol prazosin in chronic heart failure. Am. Heart J. 102:622–62}, 1981.
  • Riegger A.J.G., Libeau G., Kochsiek K.: Antidiuretic hormone in congestive heart failure. Am. J. Med 72:49–52 1982.
  • Riegger G.A.J., Liebau G., Holzschuh M, Witkowski D., Steilner H., Kochsiek K.: Role of the renin angiotensin system in the development of congestive heart failure in the dog as assessed by chronic convening enzyme blockade. Am. J. Cardiol S3: 614–618 1984.
  • Sharpe N., Murphy J., Coxon R.: Enalapril in chronic heart failure: a double blind placebo controlled trial. J. Am. Col. Cardiol 3: 471 1984.
  • Schwartz J.-C, de Baume S, Yi C-C, Enkephalin metabolism in brain and its inhibition. Progr. Neuropsychopharmacol 6: 665–671, 1982.
  • Stine S., Yang H.Y., Costa E.: Intraventricular captopril inhibits in situ metabolism of enkephalin and induces naltrexone sensitive analgesia. Pharmacologist 21: 197–203 1979.
  • Thames M.D., Jarecki M., Donald D.E.: Neural control of renin secretion in anesthetized dogs. Interaction of cardiopulmonary and carotid baroreceptors. Circ. Res. 42: 237–245, 1978.
  • Thaulow E., Ihlen H., Kjekshus J.K., Forfang K. Storstein O.: Effects of bedrest and prazosin in congestive heart failure. Acta Med. Scand. 212: 131–136, 1982.
  • Walsh W.F., and Greenberg B.H.: Results of long-term vasodilator therapy in patients with refractory congestive heart failure. Circulation 64, 499–505, 1981.
  • Wenting G.J., Man in t'Veld A.J. Woittiez A.J., Boomsma F., Laird-Meeter K., Simoons M.L., Hugenholtz P.G., and Schalekamp M.A.D.: Effects of captopril in acute and chronic heart failure correlations with plasma levels of noradrenaline, renin and aldosterone: Br. H.J., 49:65–76, 1983.
  • Zubenko G.S., Nixon R.A.: Mood-elevating effect of captopril in depressed patients. Am. J. Psychiatry 141: 110–111 1984.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.